Comments
Loading...

TransCode Therapeutics

RNAZNASDAQ
Logo brought to you by Benzinga Data
$0.350000
00.00%
After Hours: 9:29 AM EDT
15 minutes delayed

TransCode Therapeutics (NASDAQ:RNAZ) Stock, Earnings Estimates, EPS, And Revenue

TransCode Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 12
EPS Estimate
$-0.510
Quarterly Revenue Estimate
Annual Revenue
(as of Jun 30)

Analyze the earnings history of TransCode Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

TransCode Therapeutics (RNAZ) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Jun 20242024-08-14$-0.74$-0.58-27.6 %
Mar 20242024-05-15$-0.65$-0.50-30.0 %
Mar 20242024-04-01$-0.93$-10.8091.4 %
Sep 20232023-11-14$-67.20$-43.60-54.1 %

TransCode Therapeutics (RNAZ) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is TransCode Therapeutics (NASDAQ:RNAZ) reporting earnings?

A

TransCode Therapeutics (RNAZ) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.

Q

What were the latest earnings per share (EPS) for TransCode Therapeutics (NASDAQ:RNAZ)?

A

The Actual EPS was $-0.74, which missed the estimate of $-0.58.

Q

What were TransCode Therapeutics’s (NASDAQ:RNAZ) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch